| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Revenue | $8.26B | -8.8% |
| Cost of Revenue | $5.07B | -5.1% |
| Gross Profit | $3.19B | -14.1% |
| R&D Expense | $477.3M | -9.9% |
| SG&A Expense | $2.00B | -1.0% |
| Pre-tax Income | $1.10B | -31.7% |
| Income Tax | $151.8M | -54.1% |
| Net Income | $952.5M | -31.3% |
| EPS (Basic) | $8.32 |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $471.0M | -56.1% |
| Short-term Investments | $300K | -50.0% |
| Accounts Receivable | $1.80B | -16.9% |
| Inventory | $1.29B | -8.0% |
| Current Assets | $3.88B | -21.0% |
| Total Assets | $11.23B | -0.6% |
| Current Liabilities | $3.60B | +7.1% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $863.8M | -37.2% |
| Investing Cash Flow | -$982.5M | -215.0% |
| Financing Cash Flow | -$502.8M | +70.0% |
| -30.8% |
| EPS (Diluted) | $8.28 | -30.7% |
| Long-term Debt |
| $2.56B |
| -10.5% |
| Stockholders' Equity | $3.50B | -1.8% |